Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00808769 · ClinicalTrials.gov registry record · Phase 4
Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression
A Phase 4 study, sponsored by Procter and Gamble.
- Completed
- Registry status
- Phase 4
- Development phase
- 30
- Enrollment target
NCT00808769 is a Phase 4 study that has completed, run by Procter and Gamble. The registered enrollment target is 30 participants.
The verdict
NCT00808769, a Phase 4 study, has completed, sponsored by Procter and Gamble.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
Interventions
- DRUG Zegerid®
- DRUG Prilosec OTC®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-11 |
| Est. Completion | 2008-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00808769
The ClinicalTrials.gov registry entry for NCT00808769 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Procter and Gamble, which has 70 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Zegerid® is the first listed.
NCT00808769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00808769 about?
NCT00808769 is a clinical study titled "Comparison of Prilosec OTC® Versus Zegerid® for Gastric Acid Suppression". The purpose of this study is to compare Prilosec OTC® and Zegerid® in their effects on gastric acid suppression.
What is the current status of trial NCT00808769?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 30 participants. The study started on 2008-11. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00808769?
The interventions under investigation include: Zegerid® (DRUG), Prilosec OTC® (DRUG).
Who is sponsoring clinical trial NCT00808769?
This trial is sponsored by Procter and Gamble, which has 70 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.